Showing results (341-350 of 453) with videos related to
Sort By:
Pageof 46
European Urology|August 18, 2009
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohortAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trialDavid G Pfister, Barrie R Cassileth, Gary E Deng, et al.British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2017
Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma SurvivorsTalya Salz, Emily C Zabor, Peter de Nully Brown, et al.European Urology|October 29, 2024
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended DissectionKarim A Touijer, Emily A Vertosick, Daniel D Sjoberg, et al.Acta Oncologica (Stockholm, Sweden)|February 7, 2023
Impact of previous depression on the risk of suicide among prostate cancer patientsAnne Sofie Friberg, Sigrid V Carlsson, Andrew J Vickers, et al.European Urology Oncology|August 15, 2019
Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative MorbidityAntoni Vilaseca, Giuliano Guglielmetti, Emily A Vertosick, et al.European Urology|January 22, 2008
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical techniqueAndrew J Vickers, Fernando J Bianco, Mithat Gonen, et al.Cancer Prevention Research (Philadelphia, Pa.)|April 29, 2010
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancerRobert J Klein, Christer Halldén, Angel M Cronin, et al.Journal of the National Cancer Institute|April 12, 2015
Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT studyRichard J Bryant, Daniel D Sjoberg, Andrew J Vickers, et al.Pageof 46